Showing results (51-60 of 266) with videos related to
Sort By:
Pageof 27
The Lancet. Oncology|October 2, 2013
Is cancer gene therapy an empty suit?Malcolm K Brenner, Stephen Gottschalk, Ann M Leen, et al.Plos One|December 19, 2013
A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreadingStephen Gottschalk, Feng Yu, Minjun Ji, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
PiggyBac transposon-mediated gene transfer in human cellsMatthew H Wilson, Craig J Coates, Alfred L GeorgeFEBS Letters|October 26, 2005
Functional zinc finger/sleeping beauty transposase chimeras exhibit attenuated overproduction inhibitionMatthew H Wilson, Joseph M Kaminski, Alfred L GeorgeMethods in Molecular Biology (Clifton, N.J.)|February 22, 2014
Targeting piggyBac transposon integrations in the human genomeDaniel L Galvan, Claudia S Kettlun, Matthew H WilsonBlood Advances|July 3, 2025
Age-Adjusted Dosing of Fludarabine for Lymphodepletion in CAR T-cell Therapy: A Clinical Trial Simulation StudyJohn C Panetta, Aimee C Talleur, Swati Naik, et al.JCI Insight|November 5, 2020
MyD88/CD40 signaling retains CAR T cells in a less differentiated stateBrooke Prinzing, Patrick Schreiner, Matthew Bell, et al.Cancer Discovery|August 13, 2017
Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor ModelsMelinda Mata, Claudia Gerken, Phuong Nguyen, et al.Pediatric Blood & Cancer|October 16, 2018
Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinomaChristopher DeRenzo, Catherine Lam, Carlos Rodriguez-Galindo, et al.Cancer Gene Therapy|September 3, 2020
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumoursKenneth Hsu, Shiloh Middlemiss, Federica Saletta, et al.Pageof 27